ABSTRACT
INTRODUCTION: With the onset of the COVID-19 pandemic, many cancer centers pivoted to a completely virtual multidisciplinary tumor board (VTB) format. We previously published a significant rise in number of attendees and cases presented with the transition from in-person to VTB at our institution. The aim of the current study was to measure the satisfaction of participants regarding the virtual format. METHOD(S): We developed a 21-question survey including 10 questions that directly compared virtual to in-person tumor boards using a 5-point Likert scale. The survey was imported into REDCap and sent via email to all tumor board participants. Responses were collected for approximately 4 weeks (reminder email at 2 weeks) and categorized. RESULT(S): There were a total of 83 respondents, 53 of whom (64%) attended both in-person and VTB. Specialties with highest response rates were Surgical Oncology (n=24) and Medical Oncology (n=18), and tumor boards with highest participation in the survey were Breast (n=26) and Gastrointestinal (n=21). Most respondents accessed the virtual platform from the hospital or office (67%) with some participation from home (19%). Most (77%) participants were either satisfied or very satisfied with the VTB format compared with 70% for in-person tumor board. Additionally, the majority of respondents (95%) felt that VTBs had great value for discussions with community-based clinicians. In terms of direct comparison to in-person tumor boards, 40% felt that the level of distraction was higher for VTB. The large majority of respondents felt that they were somewhat more (24%) or significantly more (44%) available for VTB format. Finally, when asked regarding their preference going forward, 52% favored virtual, 6% favored in-person, and 42% favored some sort of hybrid variety type of tumor board. CONCLUSION(S): The majority of multidisciplinary tumor board participants expressed satisfaction with the virtual format and prefer it to in-person meetings going forward. VTB allows increased accessibility, opportunities to engage community oncologists, and the ability to present more cases. Drawbacks to this format included less face-to-face interaction and increased levels of distraction. Our institution is currently considering completely virtual and hybrid options moving forward.